Artesunate/Amodiaquine | Artemether/Lumefantrine | p value | |
---|---|---|---|
Overall treatment outcome | |||
ITT analysis | |||
Early treatment failure | 00 | 00 | -- |
Crude parasitological failure at day 28 | 05/249 (2%) | 10/232 (4.3%) | 0.14 |
PCR adjusted failure rate at day 28 | 04/249 (1.6%) | 09/232 (3.8%) | 0.12 |
PCR adjusted ACPR at day 28 | 242/249 (97.6%) | 218/232 (94.8%) | 0.11 |
Difference, % [95%CI] 2.7 [-0.6 - 6.2%] | |||
PP analysis | |||
Early treatment failure | 00 | 00 | -- |
Crude parasitological failure at day 28 | 05/246 (2%) | 10/227 (4.4%) | 0.14 |
PCR adjusted failure rate at day 28 | 04/246 (1.6%) | 09/227 (3.9%) | 0.12 |
PCR adjusted ACPR at day 28 | 242/246 (98.7%) | 218/227 (96.9%) | 0.16 |
Difference, % [95%CI] 1.8 [-0.76 - 4.4] |